Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$812,916
-$195,408 QoQ
Shares Held
33,759
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,443
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $15,153,316 across 7 Drug Manufacturers - General names. PFE ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,680 | $10,411,053 | |
| 2 | ABBV |
AbbVie Inc.
|
5,307 | $1,335,453 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,500 | $963,750 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,216 | $911,669 | |
| 5 | PFE |
Pfizer Inc
This page
|
33,759 | $812,916 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,180 | $413,711 | |
| 7 | JNJ |
Johnson & Johnson
|
1,200 | $304,764 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $812,916 | 33,759 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,008,324 | 35,909 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $928,994 | 37,309 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $993,949 | 39,009 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $980,726 | 40,459 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,034,733 | 40,834 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,103,223 | 41,584 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,160,754 | 40,109 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,277,986 | 45,675 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,269,312 | 45,741 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,316,883 | 45,741 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,600,153 | 48,241 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,773,147 | 48,341 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,013,112 | 49,341 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,583,315 | 50,416 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,241,212 | 51,216 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,779,995 | 53,023 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,757,943 | 53,273 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,203,344 | 54,248 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,335,356 | 54,298 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,991,207 | 50,848 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,772,661 | 48,928 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,823,861 | 49,548 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,775,287 | 48,373 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $1,705,372 | 52,248 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||